AI Article Synopsis
- Avoiding anticoagulation is essential in treating cholesterol embolization syndrome (CES), as highlighted by a case of a man with a history of pulmonary embolism who was on warfarin.
- Despite some reports suggesting anticoagulation might be safe for certain CES patients, this case ultimately led to irreversible renal failure requiring hemodialysis.
- The findings stress the risks and limited effectiveness of anticoagulation in CES, prompting further discussion on the associated treatment concerns.
Article Abstract
The avoidance of any form of anticoagulation is advised in cases of cholesterol embolization syndrome (CES). We herein describe a case of CES in a man with a history of unprovoked pulmonary embolism for which warfarinization was performed. Despite anecdotal reports of successful anticoagulation in CES patients with certain indications, irreversible renal failure, which was sufficiently severe to require chronic hemodialysis, eventually developed in our patient. Our results emphasize the pitfalls of this procedure, which imply its limited feasibility and safety. Several therapeutic concerns associated with this case are also discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398301 | PMC |
| http://dx.doi.org/10.1177/1179547616684649 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!